KEI has created a public listserve to discuss vaccine manufacturing scale up. (link)
February 19, 2021: Roundtable on Pathways to Scale Up Manufacturing Capacity for COVID-19 Vaccines – 19.
KEI has gathered data regarding vaccine manufacturing capacity in countries worldwide, across different vaccine technology platform, as well as on the outsourcing of manufacturing.
- KEI Notes on Vaccine Manufacturing Capacity outlines the manufacturers currently involved in COVID-19 vaccine manufacturing, and highlights potential COVID-19 vaccine manufacturing facilities.
- Examples of COVID-19 outsourcing/tech transfer deals provides some data on the actual sharing of manufacturing know-how, between firms.
Selected SEC filings of interest
KEI has also compiled articles regarding the Oxford/AstraZeneca COVID-19 vaccine and the role of Gates in the exclusive licensing decision. “Notes and references to some of the new stories about the Gates role in Oxford granting an exclusive license.”